Clinical and biological relevance of single-nucleotide polymorphisms and acquired somatic mutations of the BCL6 first intron in follicular lymphoma

Leukemia

Volumn 19, Issue 10, 2005, Pages 1824-1830

  Jardin, Fabrine ^a   Ruminy, P ^a   Parmentier, F ^a   Picquenot, J M ^a   Courel, M N ^a   Bertrand, P ^a   Buchonnet, G ^a   Tilly, H ^a   Bastard, C ^a  

^a CENTRE HENRI BECQUEREL   (France)

Author keywords

BCL6; Follicular lymphoma; Single nucleotide polymorphism

Indexed keywords

DNA; PROTEIN; PROTEIN BCL 6;

ADULT; AGED; ALLELE; ARTICLE; BCL6 GENE; CHROMOSOME 3Q; CONTROLLED STUDY; DNA MODIFICATION; DNA PROTEIN COMPLEX; FEMALE; FOLLICULAR LYMPHOMA; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE REARRANGEMENT; GENOTYPE; HUMAN; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION;

EID: 27144520296     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2403915     Document Type: Article

References (42)

1. Shaffer AL, Yu X, He Y, Boldrick J, Chan EP, Staudt LM. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control. Immunity 2000; 13: 199-212.
2. Dogan A, Bagdi E, Munson P, Isaacson PG. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol 2000; 24: 846-852.
3. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275-282.
4. Bernardin F, Collyn-d'Hooghe M, Quief S, Bastard C, Leprince D, Kerckaert JP. Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation. Oncogene 1997; 14: 849-855.
5. Kikuchi M, Miki T, Kumagai T, Fukuda T, Kamiyama R, Miyasaka N et al. Identification of negative regulatory regions within the first exon and intron of the BCL6 gene. Oncogene 2000; 19: 4941-4945.
6. Bastard C, Deweindt C, Kerckaert JP, Lenormand B, Rossi A, Pezzella F et al. LAZ3 rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 1994; 83: 2423-2427.
7. Jardin F, Gaulard P, Buchonnet G, Contentin N, Lepretre S, Lenain P et al. Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: A lymphoma subtype with distinct pathological, molecular and clinical characteristics. Leukemia 2002; 16: 2309-2317.
8. Horsman DE, McNeil BK, Anderson M, Shenkier T, Gascoyne RD. Frequent association of t(3;14) or variant with other lymphoma-specific translocations. Br J Haematol 1995; 89: 569-575.
9. Akasaka H, Akasaka T, Kurata M, Ueda C, Shimizu A, Uchiyama T et al. Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays. Cancer Res 2000; 60: 2335-2341.
10. Migliazza A, Martinotti S, Chen W, Fusco C, Ye BH, Knowles DM et al. Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci USA 1995; 92 12520-12524.
11. Jardin F, Buchonnet G, Parmentier F, Contentin N, Lepretre S, Lenain P et al. Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements. Leukemia 2002; 16: 2318-2325.
12. Pasqualucci L, Migliazza A, Fracchiolla N, William C, Neri A, Baldini L et al. BCL-6 mutations in normal germinal center B cells: Evidence of somatic hypermutation acting outside Ig loci. Proc Natl Acad Sci USA 1998; 95: 11816-11821.
13. Shen HM, Peters A, Baron B, Zhu X, Storb U. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 1998; 280: 1750-1752.
14. Peng HZ, Du MQ, Koulis A, Aiello A, Dogan A, Pan LX et al. Nonimmunoglobulin gene hypermutation in germinal center B cells. Blood 1999; 93: 2167-2172.
15. Vitolo U, Botto B, Capello D, Vivenza D, Zagonel V, Gloghini A et al. Point mutations of the BCL-6 gene: Clinical and prognostic correlation in B-diffuse large cell lymphoma. Leukemia 2002; 16 268-275.
16. Artiga MJ, Saez AI, Romero C, Sanchez-Beato M, Mateo MS, Navas C et al. A short mutational hot spot in the first intron of BCL-6 is associated with increased BCL-6 expression and with longer overall survival in large B-cell lymphomas. Am J Pathol 2002; 160: 1371-1380.
17. Sarsotti E, Marugan I, Benet I, Terol MJ, Sanchez-Izquierdo D, Tormo M et al. Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia. Leukemia 2004; 18: 743-746.
18. Chen PM, Yang MH, Yu IT, Lin JT, Lin YC, Fan FS et al. Low incidence of BCL-6 gene alterations for diffuse large B-cell lymphomas in Taiwan Chinese. Cancer 2002; 94: 2635-2644.
19. Bellido M, Capello D, Altes A, Estivill C, Gaidano G, Pujol R et al. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement. Haematologica 2002; 87: 908-917.
20. Lossos IS, Levy R. Mutation analysis of the 5′ noncoding regulatory region of the BCL-6 gene in non-Hodgkin lymphoma: Evidence for recurrent mutations and intraclonal heterogeneity. Blood 2000; 95: 1400-1405.
21. Lossos IS, Jones CD, Zehnder JL, Levy R. A polymorphism in the BCL-6 gene is associated with follicle center lymphoma. Leuk Lymphoma 2001; 42: 1343-1350.
22. Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989; 17: 6419.
23. Epstein AL, Levy R, Kim H, Henle W, Henle G, Kaplan HS. Biology of the human malignant lymphomas. IV. Functional characterization of ten diffuse histiocytic lymphoma cell lines. Cancer 1978; 42: 2379-2391.
24. Beckwith M, Ruscetti FW, Sing GK, Urba WJ, Longo DL. Anti-IgM induces transforming growth factor-beta sensitivity in a human B-lymphoma cell line: Inhibition of growth is associated with a downregulation of mutant p53. Blood 1995; 85: 2461-2470.
25. Seitz V, Hummel M, Anagnostopoulos I, Stein H. Analysis of BCL-6 mutations in classic Hodgkin disease of the B- and T-cell type. Blood 2001; 97: 2401-2405.
26. Lincz LF, Scorgie FE, Kerridge I, Potts R, Spencer A, Enno A. Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma. Br J Haematol 2003; 120: 1051-1054.
27. Kerridge I, Lincz L, Scorgie F, Hickey D, Granter N, Spencer A. Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk. Br J Haematol 2002; 118: 477-481.
28. Rollinson S, Levene AP, Mensah FK, Roddam PL, Allan JM, Diss TC et al. Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood 2003; 102: 1007-1011.
29. Lech-Maranda E, Baseggio L, Bienvenu J, Charlot C, Berger F, Rigal D et al. Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood 2004; 103: 3529-3534.
30. Fitzgibbon J, Grenzelias D, Matthews J, Lister TA, Gupta RK. Tumour necrosis factor polymorphisms and susceptibility to follicular lymphoma. Br J Haematol 1999; 107: 388-391.
31. Paz-y-Mino C, Fiallo BF, Morillo SA, Acosta A, Gimenez P, Ocampo L et al. Analysis of the polymorphism [gIVS12-6T>C] in the hMSH2 gene in lymphoma and leukemia. Leuk Lymphoma 2003; 44: 505-508.
32. Calvo R, Pifarre A, Rosell R, Sanchez JJ, Monzo M, Ribera JM et al. H-RAS 1 minisatellite rare alleles: A genetic susceptibility and prognostic factor for non-Hodgkin's lymphoma. J Natl Cancer Inst 1998; 90: 1095-1098.
33. Biagi JJ, Seymour JF. Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood 2002; 99: 4265-4275.
34. Lossos IS, Jacobs Y, Cleary ML, Levy R. Re: Akasaka H et al., Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays. Cancer Res., 60: 2335-2341, 2000.
35. Lossos IS, Jacobs Y, Cleary ML, Levy R. Re: Akasaka H et al., Cancer Res 2001; 61: 7363-7364.
36. Jardin F, Bastard C, Contentin N, Parmentier F, Picquenot JM, Tilly H et al. Intronic BCL-6 mutations are preferentially targeted to the translocated allele in t(3;14)(q27;q32) non-Hodgkin B-cell lymphoma. Blood 2003; 102: 1872-1876.
37. Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, Rigal D et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 1998; 91: 3574-3581.
38. Akasaka T, Lossos IS, Levy R. BCL6 gene translocation in follicular lymphoma: A harbinger of eventual transformation to diffuse aggressive lymphoma. Blood 2003; 102: 1443-1448.
39. Lossos IS, Levy R. Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5′ noncoding regulatory region of the BCL-6 gene. Blood 2000; 96: 635-639.
40. Lossos IS, Warnke R, Levy R. BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: Correlation with somatic mutations in the 5′ regulatory region of the BCL-6 gene. Leukemia 2002; 16: 1857-1862.
41. Listgarten J, Damaraju S, Poulin B, Cook L, Dufour J, Driga A et al. Predictive models for breast cancer susceptibility from multiple single nucleotide polymorphisms. Clin Cancer Res 2004; 10: 2725-2737.
42. Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412: 341-346.